Meningitis Probe Could Cause Drug Shortages, FDA Says

Law360, New York (October 22, 2012, 6:33 PM EDT) -- The investigation into the causes and extent of a widespread meningitis outbreak could lead to drug shortages for providers that buy drugs from Ameridose LLC, a compounding pharmacy affiliated with the compounder blamed for the outbreak, the U.S. Food and Drug Administration said Saturday.

Ameridose was owned and operated by the same people as the New England Compounding Center, the pharmacy that federal officials say is the source of tainted drugs that have caused almost 300 cases of meningitis in 16 states. As of Monday, 23...
To view the full article, register now.